Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R 3rd, Shen L, Nimer SD, Leavitt R, Raza A, Saba H.
Kantarjian H, et al.
Cancer. 2006 Apr 15;106(8):1794-803. doi: 10.1002/cncr.21792.
Cancer. 2006.
PMID: 16532500
Free article.
Clinical Trial.